ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM.
Budhiraja S, McManus G, Baisiwala S, Perrault EN, Cho S, Saathoff M, Chen L, Park CH, Kazi HA, Dmello C, Lin P, James CD, Sonabend AM, Heiland DH, Ahmed AU.
Budhiraja S, et al.
Neuro Oncol. 2024 Mar 20:noae059. doi: 10.1093/neuonc/noae059. Online ahead of print.
Neuro Oncol. 2024.
PMID: 38506351